In this expert interview, Deepak L. Bhatt, MD, MPH discusses guideline-based and emerging strategies for reducing recurrent ischemic stroke risk. From dietary interventions and blood pressure control to...
Preoperative diastolic dysfunction significantly elevates the risk of major adverse cardiac events and long-term mortality in patients undergoing hip fracture surgery, according to a retrospective cohort...
Despite advancements in guideline-directed therapy, heart failure readmissions remain high. At the American College of Physicians Internal Medicine Meeting 2025, Shudhanshu Alishetti, MD, outlined how...
In a large, matched-cohort study, patients with coronary artery disease receiving colchicine plus an SGLT2 inhibitor had significantly lower risks of mortality, MACE, ischemic stroke, and atrial...
A retrospective cohort study suggested that colchicine prophylaxis at urate-lowering therapy initiation may lower cardiovascular event risk in patients with gout.
A study assesses whether the dual sodium–glucose co-transporter (SGLT) 1/2 inhibitor sotagliflozin reduces ischemic events in diabetes and kidney disease.
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
Acoramidis, an oral therapy, is now approved to reduce cardiovascular-related deaths and hospitalizations in adults with hereditary or wild-type ATTR-CM.
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
